Suggestions
Paul Hallenbeck
Founder, President and Chief Scientific Officer at Seneca Therapeutics, Inc.
Paul Hallenbeck is the Founder and Chief Executive Officer of Seneca Therapeutics, Inc. He has a strong background in translational medicine and executive research development. Hallenbeck's academic credentials include a degree from the University of Illinois at Urbana-Champaign, where he likely gained foundational knowledge that has contributed to his career in biotechnology and therapeutics.
At Seneca Therapeutics, he focuses on innovative approaches to cancer treatment, particularly through the development of oncolytic virus therapies. His leadership role involves overseeing strategic initiatives and advancing the company's mission to create effective cancer therapies.
In addition to his executive responsibilities, Hallenbeck has been active in presenting at industry conferences, showcasing his expertise and the advancements made by Seneca Therapeutics in the field of oncology.123
